|
Volumn 14, Issue 3, 2008, Pages 658-660
|
Total ankle replacement for end-stage arthropathy in patients with haemophilia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIRETROVIRUS AGENT;
BLOOD CLOTTING FACTOR 8;
BLOOD CLOTTING FACTOR 8 CONCENTRATE;
EMOCLOT;
MORPHINE;
TRANEXAMIC ACID;
ADULT;
ANKLE INSTABILITY;
CD4 LYMPHOCYTE COUNT;
CLINICAL ARTICLE;
CONTINUOUS INFUSION;
ENDOPROSTHESIS;
HEMOPHILIA A;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
JOINT MOBILITY;
JOINT PROSTHESIS;
LETTER;
MALE;
OSTEOARTHROPATHY;
POSTOPERATIVE PAIN;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SURGICAL RISK;
TREATMENT RESPONSE;
WALKING DIFFICULTY;
ADULT;
ANKLE JOINT;
ARTHROPLASTY, REPLACEMENT;
FATAL OUTCOME;
HEMARTHROSIS;
HEMOPHILIA A;
HUMANS;
JOINT PROSTHESIS;
MALE;
|
EID: 43149094020
PISSN: 13518216
EISSN: 13652516
Source Type: Journal
DOI: 10.1111/j.1365-2516.2008.01650.x Document Type: Letter |
Times cited : (16)
|
References (5)
|